Search

Lorenz Leitner (Balgrist University Hospital, Switzerland) and colleagues published a new paper in The Lancet Infectious Diseases on the results of a randomised, placebo-controlled, double-blind clinical trial to investigate intravesical ph

Tao Zuo (The Chinese University of Hong Kong) and collegues published a new paper in Cell Host & Microbe on the fecal DNA virome of 930 healthy adults from two regions in China spanning six ethnicities, including urban and rural residents.

Jānis Rūmnieks (Latvian Biomedical Research and Study Center, Latvia) and colleagues published a new paper in Science Advances showing the 3D structure of 22 uncultured ssRNA phages.

Kaat Schroven (KU Leuven, Belgium) and colleagues published a new review in FEMS Microbiology Reviews on phages as drivers of bacterial virulence and their potential for biotechnological exploitation.

Alejandro González-Mora (Tecnologico de Monterrey, Mexico) and colleagues published a new review in Vaccines on phage-based vaccines for antigen delivery.

This teaching module uses PHASTER and other freely available tools for phage genome identification and phylogenetic analysis in undergraduate microbiology courses. The exercises were field-tested in classes and undergraduate directed resear

The next rendition of PHAVES will be a seminar with Dr. Panos Kalatzis (University of Copenhagen) on Sept 22 at 11:00 AM Eastern / 5:00 PM (GMT+2). Panos will tell us about the potential of phage therapy in aquaculture. Small group networki

Elections for the International Society for Viruses of Microorganisms (ISVM) Officers will take place in October 2020. We are still looking for more candidates who wish to serve on the ISVM Board and are extending the candidate application

Apply for the Viruses Young Investigator Award to win 2000 Swiss Francs, an offer to publish a paper free of charge without a fixed deadline in Viruses (subject to peer review), an engraved plaque, and an invitation to speak at the Viruses

Diana Grubb (Colorado State University) and colleagues tested a phage prebiotic produced by Deerland Enzymes (Kennesaw, Georgia) in a placebo-controlled human clinical study, and found that administration of a phage cocktail alongside a bac

DuPont Animal Nutrition announced a partnership with Proteon Pharmaceuticals toward development of phage technology for poultry producers.

Marion Bichet (Monash University) and colleagues published a new preprint showing that phage uptake by Eukaryotic cell layers represents a major sink for phages during therapy. Check out Marion's accompanying Twitter thread here!

Alan Fauconnier (Culture In Vivo ASBL) and colleagues at Phages for Global Health and the Queen Astrid Military Hospital published a new perspective in Frontiers in Microbiology on the role the WHO could play in implementing phage therapy,

Andrzej Górski (Polish Academy of Sciences) and colleagues published a new perspective in Future Medicine discussing phages in the fight against COVID-19. They describe research done in the last 15 years pointing to phage interference with

The next rendition of PHAVES will be a seminar with Dr. Panos Kalatzis (University of Copenhagen) on Sept 22 at 11:00 AM Eastern / 5:00 PM (GMT+2). Panos will tell us about the potential of phage therapy in aquaculture. Small group networki

The first iVoM event will be Sept. 17 at 11:00 AM GMT, under the theme "Ecology and evolution of microbial viruses". It will feature talks by: - Rob Edwards (Flinders University, Australia) - Ruth-Anne Sandaa (University of Bergen, Norway)

Phages for Global Health is doing fantastic things in the phage field — they've trained phage researchers in developing countries who've collectively gone on to win hundreds of thousands in grant money within just a couple of years! If you

Phage Oxford will take place September 9-10. Register here! The meeting will feature over 20 oral presentations by an international faculty of senior & junior researchers from across the world, covering phage molecular and structural biolo

Tiffany Luong (San Diego State University) and colleagues published a new phage therapy review in Clinical Therapeutics. They summarize the increasing body of clinical data on phage therapy (including a nice visual showing the pathogens pha

Kathy Lam (UCSF) and colleagues published a new preprint showing that M13 phage (engineered to express CRISPR-Cas9) can deplete specific strains of E. coli colonizing the mouse gut. They also used this system to create genetic deletions in